Effect of Pregabalin on Peripheral Neuropathic Pain in Primary Care
Author Information
Author(s): Ana Navarro, María T Saldaña, Concepción Pérez, Sandra Torrades, Javier Rejas
Primary Institution: Primary Care Health Centre Puerta del Ángel, Madrid, Spain
Hypothesis
The study aims to analyze the effect of pregabalin on pain alleviation and resource utilization in patients with peripheral neuropathic pain in primary care settings.
Conclusion
Pregabalin treatment in primary care settings significantly alleviates pain and reduces overall healthcare costs for patients with chronic peripheral neuropathic pain.
Supporting Evidence
- Patients receiving pregabalin showed a 54% reduction in pain severity compared to 34% in the non-PGB group.
- Significant reductions in healthcare resource utilization were observed in the pregabalin groups.
- Overall costs decreased significantly in the pregabalin treatment groups despite increased drug costs.
Takeaway
This study shows that taking pregabalin helps people with nerve pain feel better and saves money on healthcare costs.
Methodology
A prospective, observational study over 12 weeks comparing pregabalin treatment to non-pregabalin therapies in patients with peripheral neuropathic pain.
Potential Biases
Potential confounding by indication and selection bias due to the non-randomized nature of the study.
Limitations
The observational design may introduce confounding factors, and the study did not capture out-of-pocket costs.
Participant Demographics
Mean age of participants was 59 years, with a predominance of women (58.8%).
Statistical Information
P-Value
p < 0.001
Statistical Significance
p < 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website